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OBJECTIVES: The aim of this study was to identify variations in nervous thresholds in different phases of the
menstrual cycle in eumenorrheic women and users of oral contraceptives.
METHOD: An observational study was performed including 56 volunteers, consisting of 30 eumenorrheic
women who were non-users of oral contraceptives and 26 users of oral contraceptives. An electrical stimulator
was employed to assess their nervous thresholds, with pulses applied at a fixed frequency of 2,500 Hz,
modulated at 50 Hz, with phase variances of 20 ms, 50 ms and 100 ms. Sensitivity, motor and pain thresholds were
evaluated during five menstrual cycle phases: phase 1 - menstrual, phase 2 - follicular, phase 3 - ovulatory, phase
4 - luteal and phase 5 - premenstrual.
RESULTS: The results indicated low sensitivity thresholds of 100 ms for non-users of oral contraceptives and 50 ms
for oral contraceptive users in phase 5. Low motor thresholds of 20 ms, 50 ms and 100 ms were observed for non-
users of oral contraceptives in phase 5, while that of oral contraceptive users was 100 ms. Finally, a low pain
threshold of 100 ms was observed in phase 5, but only in the oral contraceptive group.
CONCLUSION: Nervous thresholds vary systematically across the phases of the menstrual cycle, with or without
the use of oral contraceptives. These variations should be taken into account during research performed in
women.
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& INTRODUCTION
Changes in sexual hormones can affect various body
responses. Behavioral, biochemical and physiological data
obtained from animal studies indicate that beyond their
reproductive function, ovarian hormones can influence
sensory, motor and pain responses, depending on the
menstrual cycle (MC) phase of the woman. As such, these
hormones could account for certain responses that are
specific to females (1-5).
The evidence of such effects is even stronger when
considering the high prevalence of reproductive-aged
woman presenting with chronic and behavioral diseases
such as fibromyalgia, rheumatoid arthritis, temporoman-
dibular dysfunctions, chronic pain and mood disorders
compared to males (6).
The stimulation of sensory and motor nerves as well as
nociceptive phenomena can influence the rehabilitation
process, especially for diseases in which the existence of
variations in the MC may either impair or facilitate the
treatment procedure. Therefore, obtaining a better under-
standing of female physiology, including changes related to
the MC, may enable more specific, safer and more effective
therapeutic interventions to be applied in women of
childbearing age.
Researchers have attempted to analyze the variations in
physiological, physical and behavioral responses through-
out the phases of the MC. However, their results have
varied considerably due to the different methodologies
applied in terms of the number of MC phases examined,
stimulus modalities, type of response investigated and test
parameters and protocols. This variation makes it difficult
to compare and reproduce previously reported findings (4).
Moreover, most studies have only assessed pain response
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across MC phases (1,2,4,7,8), without evaluating other
parameters, such as sensitivity and motor responses.
Thus, the aim of the present study was to evaluate
sensitivity, motor and pain thresholds during the different
menstrual phases in eumenorrheic women and women
using an oral contraceptive (OC). This evaluation was
carried out through the application of medium-frequency
excitatory motor currents and the subsequent measurement
of various physical parameters.
& MATERIALS AND METHODS
Subjects
A total of 70 women were recruited to the initial sample
population. However, 14 women were excluded for the
following reasons: four for irregularity in their menstrual
cycles; seven due to missing some of the collection sessions
(drop-out); two due to a high body mass index (BMI); and
one for a surgical reason. Thus, 56 volunteers ultimately
participated in the study, all of whom were aged between 18
and 40 years (21.27¡3.53) and presented a BMI between
18.5 and 25 kg/m2 (21.11¡2.15) and an MC of 21-35 days.
The inclusion criteria were as follows: absence of endocrine,
neurological, psychiatric and urogynecological diseases and
chronic musculoskeletal dysfunction of the upper limbs;
absence of pregnancy or breast feeding in the past six
months; and absence of drug use, except for OCs. All of the
subjects signed an informed consent form. The study was
approved by the local human ethics research committee
(protocol number 64/05).
The volunteers were divided into two groups: eumenor-
rheic women with a regular and constant menstrual cycle
ranging from 21-35 days (9,5) using no OC (non-oral
contraceptive group - NOCG) (n = 30, mean age of
23.7¡3.60 years); and women using an OC regularly for at
least 6 months (oral contraceptive group - OCG) (n= 26,
mean age of 23.03¡3.53 years).
Instrumentation
To analyze the somatic and physiological symptoms
associated with the MC, the participants were given a
questionnaire based on the Menstrual Distress
Questionnaire - MDQ (10). In this questionnaire, each
volunteer evaluates her own experience regarding her
symptoms in each phase of the cycle according to a 6-point
scale as follows: 1 =without symptoms; 2 =minimal symp-
toms; 3 =mild symptoms; 4 =moderate symptoms;
5 = intense symptoms; and 6= overwhelming symptoms.
The questionnaire was administered during each data
collection session immediately before the procedure (11).
For data collection, a pulse generator (QuarkH Dualpex
961, Piraciaba-SP, Brazil) was used. It was operated with a
biphasic pulsed current, symmetric square wave, medium
frequency of 2,500 Hz and with the electric current
modulated at a low frequency of 50 Hz. Phase variances
of 20 ms (M20), 50 ms (M50) and 100 ms (M100) were
employed. Two silica-carbon electrodes, measuring 5x3 cm,
were connected to the skin using 1 mL of a hydrosoluble gel
on both the flexor muscle of the wrist and the fingers of the
non-dominant limb. The electrodes were placed longitudin-
ally on the muscle fibers, with the first being placed at a
distance of 4 cm from the joint line of the medial epicondyle
and the second attached 4 cm from the first electrode by
means of hypoallergenic adhesive tape, according to
dermatome C6-8 (12). The device was calibrated before,
during and after the experiment using a digital oscilloscope
(Tektronix TDS 210 - Beaverton, OR, USA).
Procedures
Each volunteer was evaluated in five different MC
phases, which were defined relative to the first day of
menstruation as follows: menstrual phase, corresponding to
days 1 to 5 (P1); follicular phase, days 6 to 11 (P2); ovulatory
phase, days 12 to 16 (P3); luteal phase, days 17 to 23 (P4);
and premenstrual phase, days 24 to 28 (P5) (13). In the case
of longer or shorter cycles within the range of normality,
proportional and individual differentiation was carried out
by adding or subtracting days during the follicular period,
which was considered the variability period of the MC (14).
The method used to identify the MC phases in each
volunteer followed Lamprecht and Gummer-Strawn, based
on information about at least the six preceding MCs (15),
and Arevalo et al., based on fixed days (16). Regularity was
confirmed for at least six posterior MCs, and an estimate
was obtained from the average of all the cycles analyzed.
To maintain the same standards of experimental data
collection and the consistency of the analysis across the
groups within a given number of sessions, the MCs of the
women in the OCG were also divided into five different
phases. This methodology was applied despite the fact that
these women present constant hormonal conditions during
the use of OCs and that they only display low hormonal
levels when the contraceptives are withdrawn to allow
menstrual bleeding.
The MCs in OCG were evaluated by examining the
contraceptive package, with the cycle being considered to
begin on the first day of menstruation, based on a calendar
of 28 days. All of the OC pills used by these women were
single-phase, i.e., being composed of estrogen and proges-
terone in equal concentrations and characterized by the
cyclic ingestion of 21 pills, one per day, followed by a gap of
seven days to allow menstrual bleeding.
After defining the MC phases, the experiment was always
conducted during the middle day(s) of each phase, and
there were therefore specific data collection days for each
volunteer. The phase in which the first test was initiated was
randomized: 15 volunteers began in the menstrual phase,
nine in the proliferative phase, 11 in the ovulatory phase, 14
in the luteal phase and seven in the premenstrual phase.
All of the volunteers were informed about the application
of electric stimulation and were asked to report both the
sensation of the current and the muscular contraction
evoked by the stimulation during the different test condi-
tions. All participants received previous training so that
they were familiar with the procedure and displayed
optimal judgment of the thresholds (17-20).
The volunteers were advised not to be on a diet and not to
ingest products with caffeine, such as coffee, tea, chocolate
and sodas, alcoholic beverages or systemic medicines in the
24 hours prior to data collection.
During the procedure, the volunteers remained comfor-
tably seated, with the non-dominant arm positioned in a
supine position on the examination table. Local asepsis with
70% alcohol was applied to the skin prior to the placement
of the electrodes.
Data collection was always performed in the afternoon to
minimize the effects of morning hormonal variations and
circadian fluctuations (17,21). The data were collected at
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approximately the same time for each volunteer at a room
temperature of 23¡2 C˚ and an air humidity of 70%.
Prior to initiating data collection, the sequential order for
the application of electric currents was chosen randomly.
Then, the volunteer was instructed to report any sensation
associated with the current in response to the increase in
amplitude. The first identified sensation was defined as the
sensitivity threshold (ST). Next, the amplitude was
increased to identify minimal clear muscular contraction,
based on visual inspection or palpation, which was defined
as the motor threshold (MT). Finally, the amplitude was
increased until the first pain sensation was observed, which
was defined as the pain threshold (PT). The increase in
amplitude was maintained at the same rhythm, and the
thresholds were defined based on the amperage of the
device, which varied from 0 to 60 mA.
After the initial evaluation of the three nervous thresh-
olds, the amplitude was reduced to zero, and the same
procedure was repeated immediately after a one-minute
rest period. During this period, the parameters were
modified in accordance with the second current. This
procedure was repeated successively until the three
different types of electrical currents were applied.
At the end of the complete sequence of stimulation with
the different current parameters, there was an interval of 15
minutes after which the procedure was repeated. This
process was carried out twice. Average values from the
duplicate measures were obtained.
Statistical Analysis
The sample size was calculated previously based on the
standard deviation data obtained from a pilot study. The
results indicated that 25 volunteers were required per group
to achieve a test power of 80% and an alpha error of 0.05
(Statmate; GraphPad Software Inc, La Jolla, CA, USA).
All of the collected data were considered non-normally
distributed, according to the Shapiro-Wilk test. For intra-
group analysis of the threshold response across the MC
phases, the Friedman test, followed by the rank test, was
performed. To carry out comparisons of the thresholds
between the groups, the Mann-Whitney test was used. To
verify possible variations in MDQ scores and potential
differences between the menstrual phases within the same
group, the Friedman test was applied. All of the tests were
performed using Bioestat 4.0 (Brazil) software. A signifi-
cance level of 5% was used for all analyses.
& RESULTS
In the NOCG, the ST associated with the M100 electric
current was significantly different (p,0.05) in P1, P2, P3 and
P4 compared to P5. In the OCG, the M50 current was
different between P2 and P5 (Figure 1).
Regarding the MT, for M20 and M50 currents, variations
were observed between the first four phases and P5. For the
M100 current, the only difference was found between P2
and P5. The OCG only displayed differences for the M100
current between P2 and P5 (Figure 2).
For the PT, the only difference identified was between P2
and P5 in the OCG for the M100 current (Figure 3).
When the MDQ scores were evaluated, there was no
difference observed between the groups. However, intra-
group analysis showed differences between the phases. In
both groups, it was observed that the menstrual (P1) and
premenstrual (P5) phases were associated with a greater
intensity of the signs and symptoms of menstrual distress
compared to the other menstrual phases (i.e., the prolif-
erative (P2), ovulatory (P3) and luteal (P4) phases).
& DISCUSSION
The data collected in this study indicated that nervous
thresholds vary systematically during the different phases
of the menstrual cycle (MC), which is in accordance with the
findings of several other studies (1-5,22).
In the NOCG, the obtained ST values were higher when
the level of estradiol (E2) was elevated, with or without
reaching statistical significance. One previous study (23) in
which transcutaneous electric stimulation was used to
evaluate the variations in sensorial perception associated
with three different currents (5 Hz, 250 Hz and 2,000 Hz)
showed no difference in response between the proliferative
and luteal phases. However, when the participants were
pregnant, the threshold was increased due to the high levels
of progesterone (P4) and endogenous opioids present. While
increases in E2 and P4 can influence the endogenous opioid
system by acting as analgesics, decreases in these hormones,
such as those observed during the premenstrual phase, can
also increase pain sensitivity (18).
It is believed that the decrease in P4 observed at the end of
the luteal phase and during the premenstrual phase
increases the symptoms of premenstrual syndrome (PMS),
thus negatively influencing sensorial perception due to
increased production of the alpha sub-unit-4 of the receptor,
GABA, and/or an increase in the biosynthesis of alpha
PGF2 (1,24). E2 levels and the interaction of this hormone
with the limbic system are also closely associated with the
increased ST and PT observed in the proliferative phase.
However, the decrease in these thresholds that occurs
during the premenstrual phase in response to high levels of
E2 affects emotional and behavioral activities (25).
In the OCG, it was observed that a balance in the ST, MT
and PT was maintained throughout the phases of the MC,
except in P5, when a lower threshold was observed. Such
findings are in accordance with those of Abraham et al. (26),
who observed that women who use an OC present with
variations in the symptoms of premenstrual syndrome
during the premenstrual and menstrual phases.
The results obtained specifically for the MT associated
with the M50 current may have occurred because this
current is considered to be optimal for muscular stimula-
tion. This effect is because the type I and II muscle fibers are
intensively recruited, thus guaranteeing a more efficient and
vigorous contraction, which is dependent on the number of
activated motor units. Therefore, the threshold is reached
more quickly than when using a current with a smaller
pulse duration and in a more selective manner than when
using a longer pulse.
The MT presented the greatest variation among the
menstrual phases. A possible explanation for this finding
may be related to the genomic effects of E2 and its excitatory
function in cortical regions linked to muscular contraction
(27-29).
Inghilleri et al. (30) observed that the evoked motor
potential increased gradually depending on the elevation of
E2 across MC phases. The interaction between E2 and
glutamate receptors increases the excitability of the hippo-
campus by opening sodium channels and increasing the
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density of dendritic spines and specific synapses. The rise in
E2 levels during the proliferative phase and their peak in the
ovulatory phase influence motor behavior by allowing the
excitatory mechanisms of the motor cortex to act (31). This
increases sensory-motor functions, including activities that
demand attention and coordination (32).
The pain thresholds observed in the present study did not
vary significantly between menstrual phases with respect to
the experimental currents. One exception was found in the
OCG between P2 and P5 in relation to the M100 electric
current. As observed for the ST and MT, lower values were
obtained in P5 because the hormone levels were very low in
this phase. Conversely, higher values were observed for P2
and P3 because of the high estrogenic concentration and
estrogenic peak in these phases, respectively. It is important
to highlight that no difference was observed when using the
M20 and M50 currents due to limitations in the amplitude of
the pulse supplied by the device, thus restricting the
evaluation of the pain threshold.
Herren (33) was the first author to evaluate alterations in
pain perception in women during the MC by means of pain
induction through pressure. His findings revealed lower
thresholds during the premenstrual phase compared to the
other phases. In addition, Robinson and Short (34) applied
experimental pain induced through pressure and detected
peaks of pain sensitivity in women during the menstrual
and premenstrual phases.
Other studies using electric stimulation to induce pain
have obtained results similar to those of the present study.
Veith et al. (35) compared the five menstrual phases and
Figure 1 - The sensitivity threshold (ST) across the following five phases of the menstrual cycle (MC): menstrual (P1), follicular (P2),
ovulatory (P3), luteal (P4) and premenstrual (P5). A current of 2,500 Hz was applied in phases of 20 ms (A and B), 50 ms (C and D) and 100
ms (E and F). A, C and E represent the non-oral contraceptive group (NOCG), and B, D and F represent the oral contraceptive group
(OCG). The connections indicate statistical significance (p,0.05).
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found no significant difference in eumenorrheic women.
Tedford et al. (36) observed lower thresholds during the
phases associated with lower plasma hormonal concentra-
tions. Young-Hee et al. (37) applied continuous current and
evaluated three MC phases. These authors reported lower
thresholds in the luteal phase compared to the menstrual
phase, which is in accordance with the results from the
present study.
The relationship between the amplitude of the current
and phase duration influences the sensory, motor and pain
thresholds. Specifically, the shorter the phase duration, the
greater the amplitude required to reach these thresholds
(38,39). Our results showed that sensitivity increased in the
premenstrual phase (P5) for all of the examined physical
parameters.
However, the present findings differ from those obtained
in the study that was most methodologically similar to ours,
carried out by Giamberardino et al. (40). These authors
examined the menstrual variation of pain thresholds by
means of electric stimulation applied to different locations
and types of tissues in the body in the four following
phases: menstrual (days 2-4), peri-ovulatory (days 12-16),
luteal (days 17-22) and premenstrual (days 25-28). They
recorded higher pain thresholds during the luteal phase and
lower thresholds during the ovulatory phase. The prolif-
erative phase was not evaluated in their study.
Figure 2 - The motor threshold (MT) across the following five phases of the menstrual cycle (MC): menstrual (P1), follicular (P2),
ovulatory (P3), luteal (P4) and premenstrual (P5). A current of 2,500 Hz was applied in phases of 20 ms (A and B), 50 ms (C and D) and 100
ms (E and F). A, C and E represent the non-oral contraceptive group (NOCG), and B, D and F represent the oral contraceptive group
(OCG). The connections indicate statistical significance (p,0.05).
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The previous studies described above display numerous
methodological differences from the present work. These
differences include variations in the number of MC phases
examined, the modality of electrical stimulation, the types of
responses and parameters investigated and the applied test
protocols. These factors may account for the varying results
and difficulties encountered in comparing the findings of
these studies.
According toWiesenfeld-Hallin (6) and Riley III et al. (5), who
reviewed studies performed in both humans and animals, higher
thresholds are observed in the proliferative phase and lower
thresholds are recorded during the phases preceding a new
cycle. These conclusions support the findings of the present
study, regardless of the statistical significance of the results.
Dao et al. (41) reported that female hormones can directly
modulate the release of nitric oxide from muscles, possibly
causing vasodilatation, inflammation and pain. Moreover,
Silberstein (42) observed that serotonin levels are higher
when there is more estrogen circulating in the bloodstream,
thus explaining the increase in the incidence of chronic
headache complaints during the premenstrual phase.
Issele´e et al. (43) recorded lower pain thresholds during
the premenstrual phase in women who use OCs compared
to non-users. It is possible that in OC users, in whom
synthetic estrogens are maintained at high doses throughout
the cycle to suppress GnRH and ovulation, a significant
drop in hormonal levels may result in increased pain
perception (44). Moreover, Teepker et al. (45) concluded that
Figure 3 - The pain threshold (PT) across the following five phases of the menstrual cycle (MC): menstrual (P1), follicular (P2), ovulatory
(P3), luteal (P4) and premenstrual (P5). A current of 2,500 Hz was applied in phases of 20 ms (A and B), 50 ms (C and D) and 100 ms (E and
F). A, C and E represent the non-oral contraceptive group (NOCG), and B, D and F represent the oral contraceptive group (OCG). The
connections indicate statistical significance (p,0.05).
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compared to non-users, OC users exhibit more intense
migraines at the end of the menstrual phase.
Oelkers (46) found that women taking single-phase pills
present with increased water retention during the phases
that precede a new cycle compared to eumenorrheic
women. This additional extracellular liquid generates
greater impedance when a current is applied and results
in higher pain sensitivity in the premenstrual phase
compared to other MC phases (36).
High indices of behavioral variations such as stress,
fatigue, anxiety and mood alterations may also influence the
pain response through several different neural and physio-
logical mechanisms. This type of effect was observed in the
results obtained via the tMDQ.
One possible limitation of this study is the lack of blood
tests to evaluate hormone levels. However, to ensure the
accuracy of the results, the MCs of the volunteers were
observed for 6 months before and 6 months after collecting
the data to confirm the regularity of their cycles.
The present findings suggest that the hormonal oscilla-
tions observed across MC phases influence sensory, motor
and pain responses in women. These modifications should
be taken into account when designing therapeutic interven-
tions because women may present better therapeutic
evolution depending on the MC phase.
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